Navigation Links
Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
Date:9/7/2012

r/>Dr. Hall and his colleagues are presenting clinical data showing that LIGHT PET/CT successfully imaged brain metastases and gliomas in humans.  In doing so, the agent demonstrated a high degree of uptake and prolonged retention in tumors with no significant background uptake in normal brain tissue.  

Relative Biodistribution and Tumor Uptake of I-124-CLR1404 in Humans with Non-Small Cell Lung Cancer 
The second presentation by Dr. Hall and his colleagues reports clinical data demonstrating malignant tumor uptake of LIGHT with prolonged retention and an increasing tumor-to-background ratio in advanced non-small cell lung cancer patients.  It also shows that the relative normal organ biodistribution of LIGHT is reproducible between patients.

Relative Biodistribution and Tumor Uptake of I-131-CLR1404 in Human Subjects with Advanced Colon Cancer   
Dr. Hall and colleagues' third presentation indicates that pre-therapy planar imaging with a low dose of HOT can be used to determine its biodistribution prior to a therapeutic treatment dose of HOT.  SPECT/CT imaging, following a higher dose of HOT, successfully demonstrated selective tumor accumulation and prolonged retention in two patients with treatment-resistant metastatic colon cancer.

"We are very pleased with the initial positive LIGHT imaging data in lung and brain cancer patients, as well as the selective cancerous tumor uptake and prolonged retention of HOT in advanced colon cancer patients," said Harry Palmin, President and CEO of Novelos.  "Later this month we expect to enroll the first patient in a Phase 1-2 imaging trial of LIGHT in patients with nine other solid tumor types, as well as complete the second cohort in a U.S. multi-center Phase 1b dose-escalation trial of HOT."

About LIGHT
LIGHT is a small-molecule imaging agent that we believe has first-in-class potential for selective detection of tumors and
'/>"/>

SOURCE Novelos Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. Novelos Therapeutics Prices $5.4 Million Public Offering
4. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
5. Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11
6. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
7. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
8. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
9. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , N.J. and NEW PROVIDENCE, N.J. ... experts will present a paper on the critical ... medical oxygen storage and deliver systems at the American ... will be held at the Chicago Sheraton Hotel and ... Derrick West , program manager of ...
(Date:9/15/2014)...  Bayer HealthCare and Orion Corporation, a pharmaceutical ... , have begun to enroll patients in a ... androgen receptor inhibitor in clinical development. The study, ... prostate cancer who have rising Prostate Specific Antigen ... is designed to determine the effects of the ...
(Date:9/15/2014)... WALTHAM, Mass. , Sept. 15, 2014  Alere Inc. ... a global leader in infectious disease, toxicology, cardiology and ... of former executives, led by former CEO Ron ... and Exchange Commission and subsequently sent a letter to ... requesting one month of due diligence in an effort ...
Breaking Medicine Technology:Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 2Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 3Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 2Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 3Alere Responds To Letter From Former Executives 2
... Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... has successfully completed the validation phase of the Unifill® ... final step in the industrialization process for the Unifill ... said: "The completion of all validation tests associated with ...
... Cayenne Medical, Inc., a private sports medicine device ... System, its second generation device for treatment of traumatic ... the 2011 American Orthopaedic Society for Sports Medicine Annual ... Tal David, MD, orthopedic sports medicine specialist, San ...
Cached Medicine Technology:Unilife Successfully Completes Industrialization of Unifill Syringe 2Unilife Successfully Completes Industrialization of Unifill Syringe 3Unilife Successfully Completes Industrialization of Unifill Syringe 4Cayenne Medical, Inc. Launches CrossFix® II Meniscal Repair System 2
(Date:9/16/2014)... is relative, especially to people who tend to be ... Medical Center in the US found that seven in ... People of normal weight make this mistake much less ... to misjudge their children,s size, as youngsters misjudge their ... at Weill-Cornell Medical College, in a study in the ...
(Date:9/16/2014)... study that compared patient-reported outcomes of a broad ... that single fraction radiation therapy (SFRT) is equally ... when pain, function and quality of life are ... American Society for Radiation Oncology,s (ASTRO,s) 56th Annual ... patients, pain, function and degree of distress were ...
(Date:9/16/2014)... While abnormalities in the adrenergic and noradrenergic systems, ... to play a role in the development of ... been no genetic evidence of this connection. A ... University,s Mailman School of Public Health and the ... ADRB2 gene and childhood adversity. For individuals with ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Beginning October 1st ... a new service offering for its clients who book a ... the volume of business they buy. Most recurring visit ... during the work week, but others include clients whose unique ... pet sitter on a daily basis. The newly ...
(Date:9/16/2014)... Philadelphia, PA (PRWEB) September 16, 2014 ... #1 Pain Management practice by Ranking Arizona magazine, has ... for implementation across its enterprise. , With TPC ... had a vast data repository that was managed through ... for both the management and clinical leadership teams. ...
Breaking Medicine News(10 mins):Health News:Poor body size judgement can lead to increased tolerance of obesity 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4Health News:Evidence of genetic link to PTSD in soldiers exposed to childhood trauma 2Health News:Evidence of genetic link to PTSD in soldiers exposed to childhood trauma 3Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 2Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 3Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 2Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 3
... , MORRISTOWN, N.J., Dec. 2 ... announced that the Federal Trade Commission (FTC) has accepted a ... acquisition of privately held Arrow Group and has granted early ... the parties to close the transaction. The parties have ...
... , NASHVILLE, Tenn., Dec. 2 ... company, has appointed Pearson Talbert as chief development officer. ... will provide leadership and vision to the sales and ... hospitals grow revenues through employer partnerships and physician relationships. ...
... , MORRISTOWN, N.J., Dec. 2 Watson Pharmaceuticals, Inc. (NYSE: ... the acquisition of Arrow Group for a combination of cash ... pharmaceutical company with over $3 billion in annual revenues and ... several significant benefits to Watson shareholders as a result of ...
... taking it for macular degeneration is not advised, ... Women who take low-dose aspirin to protect their heart ... new study by Harvard University researchers found what they ... age-related macular degeneration (AMD), an eye disease that destroys ...
... ... Lighting Sunday, December 13 to remember all children who died. Hundreds of services open to ... many believe is the world,s largest mass candle lighting. , ... Oak Brook IL (PRWEB) December 2, 2009 -- Tens of ...
... ... to do better, be better and take better self-care. What to do to ensure the ... make self-care the #1 priority. At Garden of Eve safe skin care is the primary ... consumer guide to safe cosmetic products. , ...
Cached Medicine News:Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Aegis Health Group Hires Pearson Talbert as Chief Development Officer 2Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5Health News:In Women, Aspirin Might Ward Off Eye Trouble 2Health News:Bereaved Families Unite for Compassionate Friends Worldwide Candle Lighting 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 3Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: